This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07055/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07055/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07055/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07055/identifier/drugbank/
n5http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07055/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07055
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n5:DB07055 n14:DB07055
dcterms:title
2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione
adms:identifier
n8:1289593 n9:99443526 n10:DB07055 n11:3G3 n13:1081425
n3:IUPAC-Name
n6:271B4546-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B454C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B454B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B4548-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B4549-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B454A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B4544-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B4545-363D-11E5-9242-09173F13E4C5 n6:271B4542-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B4543-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B4552-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B4553-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B454D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B454E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B4550-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B454F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B4551-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B4558-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B455A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B455B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B4557-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B4556-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B4559-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B4547-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B4554-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B4555-363D-11E5-9242-09173F13E4C5